Tom Lee's BitMine Hits $10,8 Billion in Assets, Reinforces 5% ETH Target
- BitMine accumulates 2,15 million ETH in treasury
- Total assets exceed $10 billion in cryptocurrencies
- The goal is to reach 5% of Ethereum's circulating supply.
BitMine Immersion, a crypto treasury company chaired by Tom Lee, reported that its total assets in cryptocurrencies and cash reached $10,8 billion. The milestone was achieved after purchasing approximately 82.233 ETH, valued at $370 million, since the last update released in early September.
With the new acquisition, the company now holds 2.151.676 ETH, equivalent to approximately US$9,75 billion, in addition to 192 BTC (US$22,1 million), a US$214 million stake in the WLD-linked Eightco treasury, and US$569 million in unencumbered cash. The data positions BitMine as the largest institutional holder of Ethereum, followed by SharpLink, with 837.230 ETH, and The Ether Machine, which holds 495.360 ETH.
In the overall ranking of public companies with crypto treasuries, BitMine ranks second, behind only MicroStrategy, which holds 638.985 BTC valued at approximately US$73,5 billion.
The company's growth is supported by institutional investors such as Cathie Wood's Ark Invest, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital. The stated strategy is to acquire approximately 5% of Ethereum's circulating supply, estimated at 6,04 million tokens.
Tom Lee highlighted the importance of the move: “BitMine has nearly $11 billion in total cryptocurrency assets, surpassing the 2 million ETH milestone,” stated He added that the convergence of Wall Street, blockchain, and artificial intelligence is creating a supercycle of Ethereum's value. "The power law benefits large ETH holders, so we're looking for the '5% alchemy' of ETH."
The executive further reinforced: "We continue to believe that Ethereum will be one of the largest macroeconomic transactions in the next 10 to 15 years. Wall Street and AI migrating to the blockchain should lead to a major transformation of the current financial system. And most of this is happening on Ethereum."
BitMine shares, traded under the ticker BMNR, are among the most active in the US market, moving an average of US$2 billion per day over the last five trading sessions. Last Friday, the stock closed up 15,3% at US$55,09, accumulating a 572% increase in value by 2025, despite a 1,8% drop in pre-market trading on Monday.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

